GLP-1s Now FDA-Approved for Fatty Liver Disease
Semaglutide and tirzepatide both FDA-approved for MASH. 63% resolution rate, fibrosis reversal in trials. What the data shows and sourcing options.
FDA actions, trial readouts, vendor coverage and pricing reports — curated for peptide buyers and clinicians.
New articles delivered to your inbox every morning. Free.
Semaglutide and tirzepatide both FDA-approved for MASH. 63% resolution rate, fibrosis reversal in trials. What the data shows and sourcing options.
The DIY recipe is simple. The risks aren't. Why homemade bac water fails sterility, concentration, and pyrogen tests that take 30 seconds to buy around.
Teen peptide injection rates are surging via looksmaxxing culture. Contamination data, organ-damage risks, and what COA-verified sourcing actually looks like.
Largest GLP-1 cardiovascular meta-analysis yet — 11 RCTs, 91,490 patients, 2.7-year follow-up. Semaglutide and liraglutide lead. What it means for you.
TRIUMPH-1 Phase 3 data drops: 30.3% body weight loss at 104 weeks, 2,339 patients. What the numbers mean for the NDA and buyers.
Europe's top obesity body updated its algorithm May 12 — tirzepatide leads for weight loss, semaglutide for liver fibrosis. What it means for buyers.
Amgen's 300-patient MARITIME-Switch trial tests transitioning from weekly semaglutide or tirzepatide to MariTide every 8 weeks or quarterly.
Peptides are amino acid chains that signal specific receptors. Key categories: growth hormone, metabolic, healing, and cognitive.
Not all stacks are equal — 3 combos stand out for synergy. 13 stacks with exact doses, timing, and which combos to avoid.
GH release, mitochondrial repair, metabolic signaling, and immune modulation — four pathways that explain every peptide.
FDA gave 4P004 — intra-articular liraglutide for knee osteoarthritis — Fast Track in April. What it means for GLP-1 buyers and OA patients.
New nference preprint of 670,422 GLP-1 users shows tirzepatide patients lose 2% more lean mass at 12 months. Depletive metabotype hits 10.3%.
Novo's ECO 2026 sub-analysis shows early-responder patients lost nearly 28% on 7.2 mg. What it means for research-peptide dosing and vendor sourcing.
New ATTAIN-MAINTAIN trial: switching from injectable semaglutide or tirzepatide to daily orforglipron held 75-79% of weight loss over 52 weeks.
One reconstitution ratio gets the math right every time. Full chart for BPC-157, TB-500, GHK-Cu, semaglutide, tirzepatide, and retatrutide.
A 24-month semaglutide cohort in adults 65+ shows accelerated muscle loss + falling gait speed. What it means for older GLP-1 buyers.
Cloudy after mixing? Almost always the bac water — not the peptide. Whether it's safe to inject, the 7 causes ranked, and how to prevent it.
Three ways to buy bac water for peptides — vendor-sourced, pharmacy, or marketplace. Typical 30 mL runs $20-35. Which path gives you COA-verified quality without ruining a $300 vial.